New Drug Rusfertide Shows Promise in Treating Polycythemia Vera, Revealing Positive Outcomes Polycythemia vera falls under the category of chronic myeloproliferative neoplasms, which disrupt the normal production of blood cells within the bone marrow. by Inno Flores
Chatbots Could Be Suffering from Confirmation Bias When Tackling Controversial Issues: John Hopkins Study